​

Kazia Therapeutics Ownership | Who Owns Kazia Therapeutics?

OverviewChart

Kazia Therapeutics Ownership Summary

Kazia Therapeutics is owned by 0.89% institutional investors, and 99.11% retail investors. Morgan stanley is the largest institutional shareholder, holding 0.84% of KZIA shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.03% of its assets in Kazia Therapeutics shares.

KZIA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockKazia Therapeutics0.89%-99.11%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Morgan stanley201.08K0.84%$45.97K
Susquehanna group, llp41.48K0.17%$9.46K
Virtu financial39.28K0.16%$9.00K
Ubs group23.34K0.10%$5.34K
Citadel advisors4.57K0.02%$1.04K
Wells fargo & company/mn500.000.00%$114.00
Two sigma securities---
Bnp paribas arbitrage, snc---
Xtx topco---
Allworth financial lp---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Virtu financial39.28K0.00%$9.00K
Susquehanna group, llp41.48K-$9.46K
Rhumbline advisers---
Advisornet financial---
Ground swell capital---
Hsbc---
Traynor capital management---
Jpmorgan chase3.00-$1.00
Bnp paribas arbitrage, snc---
Ubs group23.34K-$5.34K

Top Buyers

HolderShares% AssetsChange
Susquehanna group, llp41.48K-41.48K
Virtu financial39.28K0.00%39.28K
Ubs group23.34K-23.34K
Citadel advisors4.57K-4.57K
Morgan stanley201.08K-3.23K

Top Sellers

HolderShares% AssetsChange
Hsbc---63.96K
Bnp paribas arbitrage, snc---63.57K
Rhumbline advisers---27.81K
Xtx topco---18.49K
Two sigma securities---18.42K

New Positions

HolderShares% AssetsChangeValue
Susquehanna group, llp41.48K-41.48K$9.46K

Sold Out

HolderChange
Advisornet financial-5.00
Allworth financial lp-87.00
Traynor capital management-10.00K
Ground swell capital-11.15K
Two sigma securities-18.42K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20241850.00%2,129,596443.93%-33.31%1385.71%1-
Jun 30, 2024129.09%391,5175.46%13935.10%740.00%--100.00%
Mar 31, 202411-38.89%371,232-92.40%-4.25%5-58.33%4300.00%
Dec 31, 20231880.00%4,883,3381959.24%268.36%12500.00%1-50.00%
Sep 30, 20231011.11%237,143-16.63%138.83%2-33.33%2-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Nasdaq Composite Index1.48K0.03%-

Recent Insider Transactions

DateNameRoleActivityValue
Nov 05, 2013AUSTIN JOSIAH T-Sell$143.69K
Nov 04, 2013AUSTIN JOSIAH T-Sell$153.03K
Oct 28, 2013AUSTIN JOSIAH T-Sell$231.24K
Oct 29, 2013AUSTIN JOSIAH T-Sell$6.64K
Oct 25, 2013AUSTIN JOSIAH T-Sell$386.34K

Insider Transactions Trends

DateBuySell
2013 Q4-6
2013 Q1-7
2012 Q4--
2012 Q2--
2011 Q4--

KZIA Ownership FAQ

Who Owns Kazia Therapeutics?

Kazia Therapeutics shareholders are primarily institutional investors at 0.89%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Kazia Therapeutics's industry, Biotech Stocks , is 109.70%, which Kazia Therapeutics falls below.

Who owns the most shares of Kazia Therapeutics?

Kazia Therapeutics’s largest shareholders are Morgan stanley (201.08K shares, 0.84%), Susquehanna group, llp (41.48K shares, 0.17%), and Virtu financial (39.28K shares, 0.16%). Together, they hold 1.18% of Kazia Therapeutics’s total shares outstanding.

Does Blackrock own Kazia Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Kazia Therapeutics.

Who is Kazia Therapeutics’s biggest shareholder by percentage of total assets invested?

Virtu financial is Kazia Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 39.28K Kazia Therapeutics shares, valued at 9K$.

Who is the top mutual fund holder of Kazia Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Kazia Therapeutics shares, with 0.03% of its total shares outstanding invested in 1.48K Kazia Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools